載入...
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
ErbB2 is a type of receptor tyrosine kinase, which is known to be involved in tumorigenesis, tumor aggressiveness, and clinical outcome. ErbB2-targeting therapy using therapeutic antibodies has been successful in breast cancer treatment. However, the need for repeated treatments and the high cost ar...
Na minha lista:
| 發表在: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356551/ https://ncbi.nlm.nih.gov/pubmed/32599712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12060585 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|